@ARTICLE{
author={Miljkovic Milena M,Bielen C,Simic-Koumoutsaris M,Urakpo A},
year={2018},
title={A Review of Benefit-Risk Assessment Over the Product Lifecycle},
journal={DRUG SAFETY},
volume={41},
number={11},
pages={1169-1169},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Miljkovic Milena M,Bielen C,Dobrin D,Kisic Vesna},
year={2017},
title={Challenges of Identifying Safety Signals in Clinical Trials},
journal={DRUG SAFETY},
volume={40},
number={10},
pages={940-940},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Miljkovic Milena M,Dobric Silva Lj,Dragojevic-Simic Viktorija M},
year={2012},
title={Accuracy and reproducibility of two scales in causality assessment of unexpected hepatotoxicity},
journal={JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS},
volume={37},
number={2},
pages={196-203},
document_type={Article},
} 

@ARTICLE{
author={Miljkovic Milena M,Dobric Silva Lj,Dragojevic-Simic Viktorija M},
year={2011},
title={Consistency between causality assessments obtained with two scales and their agreement with clinical judgments in hepatotoxicity},
journal={PHARMACOEPIDEMIOLOGY AND DRUG SAFETY},
volume={20},
number={3},
pages={272-285},
document_type={Article},
} 

@ARTICLE{
author={Miljkovic Milena M,Djukic Ljiljana L},
year={2000},
title={Analysis of drug utilization in Serbia during the years 1996 and 1997},
journal={PHARMACOEPIDEMIOLOGY AND DRUG SAFETY},
volume={9},
number={1},
pages={59-64},
document_type={Article},
}